KATHARINE BUCK: Open Payments
NPI 1376159145 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,055 in 177 payments from 22 companies in 2025. Trend: 2023 $2,416 · 2024 $3,439 · 2025 $4,055
Food & beverage: $4,056
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $541 |
| Novo Nordisk Inc | 20 | $409 |
| ABBVIE INC. | 16 | $407 |
| Amgen Inc. | 20 | $337 |
| Daiichi Sankyo Inc. | 9 | $303 |
| Axsome Therapeutics, Inc. | 6 | $265 |
| PFIZER INC. | 12 | $232 |
| Novartis Pharmaceuticals Corporation | 11 | $212 |
| Lilly USA, LLC | 9 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $191 |
Products named: FARXIGA, Ozempic, VRAYLAR, INJECTAFER, Auvelity, ELIQUIS, LEQVIO, MOUNJARO.
Industry payments across FL — which companies pay providers there.
